Brentuximab vedotin and nivolumab for relapsed or refractory classic Hodgkin lymphoma: Long-term follow-up results from the single-arm phase 1/2 study Meeting Abstract
| Authors: | Moskowitz, A. J.; Advani, R. H.; Bartlett, N. L.; Vose, J. M.; Ramchandren, R.; Feldman, T. A.; LaCasce, A. S.; Christian, B. A.; Ansell, S. M.; Moskowitz, C. H.; Brown, L.; Taft, D.; Ansari, S.; Zak, D. E.; Sacchi, M.; Manley, T.; Herrera, A. F. |
| Abstract Title: | Brentuximab vedotin and nivolumab for relapsed or refractory classic Hodgkin lymphoma: Long-term follow-up results from the single-arm phase 1/2 study |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Start Page: | 238 |
| Language: | English |
| ACCESSION: | WOS:000518218500563 |
| DOI: | 10.1182/blood-2019-122576 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 624 -- Source: Wos |
